Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Alaunos Therapeutics, Inc.

NASDAQ: TCRT · Life Sciences · 6 alerts · CIK 1107421

Share price
$1.60Close, Nov 16
Market cap
$4.06M
Shares outstanding
2.54MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Alaunos Therapeutics, Inc. filings on SEC EDGAR ↗

9:29 AM ET 8-K
M&A Deal

Alaunos Therapeutics M&A Deal with Velaris Therapeutics, Inc.

Alaunos Therapeutics completed the acquisition of Velaris Therapeutics through a two-step merger process, making Velaris a wholly owned subsidiary. As consideration, Alaunos issued 105,286 shares of Series B Preferred Stock and 33,054 shares of Series C Preferred Stock to Velaris stockholders, which are convertible into common stock subject to shareholder approval. Following the deal, Alaunos plans to change its name to Velaris Therapeutics, Inc. and effect a reverse stock split.

Counterparty
Velaris Therapeutics, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.